Market revenue in 2023 | USD 7.1 million |
Market revenue in 2030 | USD 12.2 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | 100 to 150 mm |
Fastest growing segment | Smaller Than 100 mm |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 100 to 150 mm, Larger Than 150 mm, Smaller Than 100 mm |
Key market players worldwide | Smiths Group PLC, Integra LifeSciences, Cook Medical, CooperSurgical, Medline Industries, Rocket Pharmaceuticals Inc, Becton Dickinson & Co, BPB Medica, Laboratoire CCD |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to amniocentesis needle market will help companies and investors design strategic landscapes.
100 to 150 mm was the largest segment with a revenue share of 54.93% in 2023. Horizon Databook has segmented the China amniocentesis needle market based on 100 to 150 mm, larger than 150 mm, smaller than 100 mm covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China amniocentesis needle market , including forecasts for subscribers. This country databook contains high-level insights into China amniocentesis needle market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account